{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Dachaihu-tang", "Daesiho-tang", "Dai-saiko-to", "Herbal medicine", "Non-alcoholic fatty liver disease", "Obesity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32005283", "DateCompleted": {"Year": "2020", "Month": "11", "Day": "19"}, "DateRevised": {"Year": "2020", "Month": "11", "Day": "19"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "31"}], "Language": ["eng"], "ELocationID": ["128", "10.1186/s13063-020-4068-y"], "Journal": {"ISSN": "1745-6215", "JournalIssue": {"Volume": "21", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Jan", "Day": "31"}}, "Title": "Trials", "ISOAbbreviation": "Trials"}, "ArticleTitle": "Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial.", "Pagination": {"StartPage": "128", "MedlinePgn": "128"}, "Abstract": {"AbstractText": ["The high prevalence of obesity and non-alcoholic fatty acid disease has become an important public health problem. Daesiho-tang (DST) is an herbal medicine widely used to treat obesity, metabolic syndrome and liver diseases. This pilot study will assess the feasibility of using DST in obese patients with a non-alcoholic fatty liver disease (NAFLD) prior to undertaking a full-scale clinical trial.", "This is a study protocol for a randomised, double-blind, parallel-group, stratified, placebo-controlled pilot trial. We will recruit a total of 60 participants with NAFLD who have a body mass index \u2265\u200925\u2009kg/m<sup>2</sup>. They will take either DST or placebo (3\u2009g, three times daily) for 12\u2009weeks with a 4-week follow-up period. The effects of DST will be evaluated by the mean change in body weight as the primary measurement and other secondary parameters (body composition, anthropometric measurements, blood tests, hepatic fat quantification through transient elastography and a physical symptoms questionnaire). Faecal samples will be collected before and after the intervention for a gut microbial analysis.", "In anticipation of conducting further large-scale trials, in this study we will explore the effect of DST on weight loss and obesity-related markers, along with NAFLD-related clinical parameters, in obese patients with NAFLD. Furthermore, it will provide insight into the DST pharmacological mechanism of action through a gut microbiome analysis.", "Korean Clinical Trial Registry, KCT0003554. Registered on 25 February 2019."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea."}], "LastName": "Han", "ForeName": "Kyungsun", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea."}], "LastName": "Kwon", "ForeName": "Ojin", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea."}], "LastName": "Park", "ForeName": "Hyo-Ju", "Initials": "HJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea."}], "LastName": "Jung", "ForeName": "So-Young", "Initials": "SY"}, {"Identifier": ["0000-0003-1277-3329"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea. yangunja@kiom.re.kr."}], "LastName": "Yang", "ForeName": "Changsop", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Liver-Immune Research Center, Dunsan Hospital of Daejeon University, Daejeon, Republic of Korea. ckson@dju.kr."}], "LastName": "Son", "ForeName": "Chang-Gue", "Initials": "CG"}], "GrantList": [{"GrantID": "KSN1522120", "Agency": "Korea Institute of Oriental Medicine", "Country": ""}], "PublicationTypeList": ["Clinical Trial Protocol", "Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Trials", "NlmUniqueID": "101263253", "ISSNLinking": "1745-6215"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "daesungki-tang"}, {"RegistryNumber": "0", "NameOfSubstance": "daisaikoto"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Body Mass Index"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["methods"], "DescriptorName": "Elasticity Imaging Techniques"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gastrointestinal Microbiome"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["diagnostic imaging", "drug effects"], "DescriptorName": "Liver"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["methods"], "DescriptorName": "Medicine, East Asian Traditional"}, {"QualifierName": ["complications", "diagnosis", "drug therapy"], "DescriptorName": "Non-alcoholic Fatty Liver Disease"}, {"QualifierName": ["complications", "diagnosis", "drug therapy"], "DescriptorName": "Obesity"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Pilot Projects"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Randomized Controlled Trials as Topic"}, {"QualifierName": [], "DescriptorName": "Republic of Korea"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6\u201310. doi: 10.1016/j.metabol.2018.09.005.", "ArticleIdList": ["10.1016/j.metabol.2018.09.005", "30253139"]}, {"Citation": "Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32(9):1431\u20131437. doi: 10.1038/ijo.2008.102.", "ArticleIdList": ["10.1038/ijo.2008.102", "18607383"]}, {"Citation": "Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523\u20131529. doi: 10.1001/jama.282.16.1523.", "ArticleIdList": ["10.1001/jama.282.16.1523", "10546691"]}, {"Citation": "Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89(6):2583\u20132589. doi: 10.1210/jc.2004-0535.", "ArticleIdList": ["10.1210/jc.2004-0535", "15181027"]}, {"Citation": "Ara\u00fajo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: what we need in the future. Liver Int. 2018;38(Suppl 1):47\u201351. doi: 10.1111/liv.13643.", "ArticleIdList": ["10.1111/liv.13643", "29427488"]}, {"Citation": "Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107(5):450\u2013455. doi: 10.1016/S0002-9343(99)00271-5.", "ArticleIdList": ["10.1016/S0002-9343(99)00271-5", "10569299"]}, {"Citation": "Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013;5(5):1544\u20131560. doi: 10.3390/nu5051544.", "ArticleIdList": ["10.3390/nu5051544", "PMC3708335", "23666091"]}, {"Citation": "Han EN, Cheong ES, Lee JI, Kim MC, Byrne CD, Sung KC. Change in fatty liver status and 5-year risk of incident metabolic syndrome: a retrospective cohort study. Clin Hypertens. 2015;21:22. doi: 10.1186/s40885-015-0032-7.", "ArticleIdList": ["10.1186/s40885-015-0032-7", "PMC4750798", "26893932"]}, {"Citation": "Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005\u20132023. doi: 10.1002/hep.25762.", "ArticleIdList": ["10.1002/hep.25762", "22488764"]}, {"Citation": "Li CY, Chiu CH, Huang HS, Lin CH, Wu TS. High-performance liquid chromatographic method for simultaneous quantification of eight major biologically active ingredients in \u2018Da-Chai-Hu-Tang\u2019 preparation. Biomed Chromatogr. 2006;20(4):305\u2013308. doi: 10.1002/bmc.572.", "ArticleIdList": ["10.1002/bmc.572", "16161181"]}, {"Citation": "Hussain A, Yadav MK, Bose S, Wang JH, Lim D, Song YK, et al. Daesiho-Tang is an effective herbal formulation in attenuation of obesity in mice through alteration of gene expression and modulation of intestinal microbiota. PLoS One. 2016;11(11):e0165483. doi: 10.1371/journal.pone.0165483.", "ArticleIdList": ["10.1371/journal.pone.0165483", "PMC5094769", "27812119"]}, {"Citation": "Song M, Kim E, Kong J, Lee J, Shin B, Ryu D, et al. Inhibitory effect of Daesiho-tang (Dachaihu-tang) extracts on high-fat diet induced obesity [in Korean] J Oriental Rehab Med. 2008;18(3):41\u201349."}, {"Citation": "Yeo UH, Jo HJ, Kim HH. Effects of DaeSiHo-Tang extract on hypertension and arterial contraction [in Korean] Korean J Oriental Physiol Pathol. 2005;19(6):1573\u20131579."}, {"Citation": "Park SD, Yun BG. Effects of Daesihotang and its component groups on diabetes, free radical and antioxidative defense system in alloxan induced diabetic rats. Herbal Formula Sci. 2001;9(1):289\u2013317."}, {"Citation": "Yoshie F, Iizuka A, Komatsu Y, Matsumoto A, Itakura H, Kondo K. Effects of Dai-saiko-to (Da-Chai-Hu-Tang) on plasma lipids and atherosclerotic lesions in female heterozygous heritable Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits. Pharmacol Res. 2004;50(3):223\u2013230. doi: 10.1016/j.phrs.2004.02.003.", "ArticleIdList": ["10.1016/j.phrs.2004.02.003", "15225663"]}, {"Citation": "Yamamoto K, Ogawa Y, Yanagita T, Morito F, Fukushima N, Ozaki I, et al. Pharmacological effects of dai-saiko-to on lipid biosynthesis in cultured human hepatocyte HepG2 cells. J Ethnopharmacol. 1995;46(1):49\u201354. doi: 10.1016/0378-8741(95)01227-5.", "ArticleIdList": ["10.1016/0378-8741(95)01227-5", "7475122"]}, {"Citation": "Berthon BS, Gibson PG, McElduff P, MacDonald-Wicks LK, Wood LG. Effects of short-term oral corticosteroid intake on dietary intake, body weight and body composition in adults with asthma \u2013 a randomized controlled trial. Clin Exp Allergy. 2015;45(5):908\u2013919. doi: 10.1111/cea.12505.", "ArticleIdList": ["10.1111/cea.12505", "25640664"]}, {"Citation": "Greenway FL, De Jonge L, Blanchard D, Frisard M, Smith SR. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. Obes Res. 2004;12(7):1152\u20131157. doi: 10.1038/oby.2004.144.", "ArticleIdList": ["10.1038/oby.2004.144", "15292480"]}, {"Citation": "Coffey CS, Steiner D, Baker BA, Allison DB. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. In J Obesity. 2004;28(11):1411\u20131419. doi: 10.1038/sj.ijo.0802784.", "ArticleIdList": ["10.1038/sj.ijo.0802784", "15356670"]}, {"Citation": "Pan JJ, Fallon MB. Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol. 2014;6(5):274\u2013283. doi: 10.4254/wjh.v6.i5.274.", "ArticleIdList": ["10.4254/wjh.v6.i5.274", "PMC4033285", "24868321"]}, {"Citation": "Lee K, Sung JA, Kim JS, Park TJ. The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in Koreans. Diabetes Metab Res Rev. 2009;25(2):150\u2013155. doi: 10.1002/dmrr.924.", "ArticleIdList": ["10.1002/dmrr.924", "19117027"]}, {"Citation": "Kanter R, Caballero B. Global gender disparities in obesity: a review. Adv Nutr. 2012;3(4):491\u2013498. doi: 10.3945/an.112.002063.", "ArticleIdList": ["10.3945/an.112.002063", "PMC3649717", "22797984"]}, {"Citation": "Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther. 2017;34(6):1291\u20131326. doi: 10.1007/s12325-017-0556-1.", "ArticleIdList": ["10.1007/s12325-017-0556-1", "PMC5487879", "28526997"]}, {"Citation": "Oh JY, Yang YJ, Kim BS, Kang JH. Validity and reliability of Korean version of International Physical Activity Questionnaire (IPAQ) Short Form. J Korean Acad Fam Med. 2007;28(7):532\u2013541."}, {"Citation": "World Health Organization (WHO) Waist circumference and waist\u2013hip ratio: report of a WHO expert consultation, Geneva, 8\u201311 December 2008. Geneva: WHO; 2011."}, {"Citation": "Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43(8):617\u2013649. doi: 10.3109/07853890.2010.518623.", "ArticleIdList": ["10.3109/07853890.2010.518623", "21039302"]}, {"Citation": "Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, Milic S. Transient elastography (FibroScan\u00ae) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - where do we stand? World J Gastroenterol. 2016;22(32):7236\u20137251. doi: 10.3748/wjg.v22.i32.7236.", "ArticleIdList": ["10.3748/wjg.v22.i32.7236", "PMC4997649", "27621571"]}, {"Citation": "Petta S, Wong VW, Camma C, Hiriart JB, Wong GL, Marra F, et al. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values. Hepatology. 2017;65(4):1145\u20131155. doi: 10.1002/hep.28843.", "ArticleIdList": ["10.1002/hep.28843", "27639088"]}, {"Citation": "Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res. 1991;36(3):291\u2013298. doi: 10.1016/0165-1781(91)90027-M.", "ArticleIdList": ["10.1016/0165-1781(91)90027-M", "2062970"]}, {"Citation": "Gift AG. Visual analogue scales: measurement of subjective phenomena. Nurs Res. 1989;38(5):286\u2013288. doi: 10.1097/00006199-198909000-00006.", "ArticleIdList": ["10.1097/00006199-198909000-00006", "2678015"]}, {"Citation": "LaChapelle DL, Finlayson MA. An evaluation of subjective and objective measures of fatigue in patients with brain injury and healthy controls. Brain Inj. 1998;12(8):649\u2013659. doi: 10.1080/026990598122214.", "ArticleIdList": ["10.1080/026990598122214", "9724836"]}, {"Citation": "Park HS, Sung SW, Ou SW, Lee KY, Kim BS, Han JH, et al. Development of Korean version of obesity-related quality of life scale [in Korean] J Korean Soc Study Obes. 2003;12(4):280\u2013293."}, {"Citation": "Kang KW, Jini-Seok M, Kang BG, Bo-Yong K, Choi SM. The comparison of pattern identification diagnosis according to symptom scale based on obesity pattern identification questionnaire [in Korean] J Korean Med Obes Res. 2009;9(1):37\u201344."}, {"Citation": "Kang B, Moon J, Choi S. A reliability analysis of syndrome differentiation questionnaire for obesity. Korean J Oriental Med. 2007;13(1):109\u2013114."}, {"Citation": "Rodgers RJ, Tsch\u00f6p MH, Wilding JPH. Anti-obesity drugs: past, present and future. Dis Model Mech. 2012;5(5):621\u2013626. doi: 10.1242/dmm.009621.", "ArticleIdList": ["10.1242/dmm.009621", "PMC3424459", "22915024"]}, {"Citation": "Wang Y, Fan X, Qu H, Gao X, Cheng Y. Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine. Curr Top Med Chem. 2012;12(12):1356\u20131362. doi: 10.2174/156802612801319034.", "ArticleIdList": ["10.2174/156802612801319034", "22690682"]}, {"Citation": "Hasani-Ranjbar S, Jouyandeh Z, Abdollahi M. A systematic review of anti-obesity medicinal plants - an update. J Diabetes Metab Disord. 2013;12:28. doi: 10.1186/2251-6581-12-28.", "ArticleIdList": ["10.1186/2251-6581-12-28", "PMC3914705", "23777875"]}, {"Citation": "Xiao J, So KF, Liong EC, Tipoe GL. Recent advances in the herbal treatment of non-alcoholic fatty liver disease. J Tradit Complement Med. 2013;3(2):88\u201394. doi: 10.4103/2225-4110.110411.", "ArticleIdList": ["10.4103/2225-4110.110411", "PMC3924972", "24716162"]}, {"Citation": "Donguibogam Committee . Translated Donguibogam. Seoul: Bubinmunwha Press; 1999. p. 2198."}, {"Citation": "Zhou S. Thirty cases of chronic cholecystitis treated by acupuncture and oral administration of da chai hu tang. J Tradit Chin Med. 2008;28(3):173\u2013174. doi: 10.1016/S0254-6272(08)60039-4.", "ArticleIdList": ["10.1016/S0254-6272(08)60039-4", "19004196"]}, {"Citation": "Sporea I, Popescu A, Dumitrascu D, Brisc C, Nedelcu L, Trifan A, et al. Nonalcoholic fatty liver disease: status quo. J Gastrointestin Liver Dis. 2018;27(4):439\u2013448.", "ArticleIdList": ["30574627"]}, {"Citation": "Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262\u20131267. doi: 10.1126/science.1223813.", "ArticleIdList": ["10.1126/science.1223813", "22674330"]}, {"Citation": "Tremaroli V, B\u00e4ckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489(7415):242\u2013249. doi: 10.1038/nature11552.", "ArticleIdList": ["10.1038/nature11552", "22972297"]}, {"Citation": "B\u00e4ckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101(44):15718\u201315723. doi: 10.1073/pnas.0407076101.", "ArticleIdList": ["10.1073/pnas.0407076101", "PMC524219", "15505215"]}, {"Citation": "Li H, Zhou M, Zhao A, Jia W. Traditional Chinese medicine: balancing the gut ecosystem. Phytother Res. 2009;23(9):1332\u20131335. doi: 10.1002/ptr.2590.", "ArticleIdList": ["10.1002/ptr.2590", "19253310"]}, {"Citation": "Xu J, Chen HB, Li SL. Understanding the molecular mechanisms of the interplay between herbal medicines and gut microbiota. Med Res Rev. 2017;37(5):1140\u20131185. doi: 10.1002/med.21431.", "ArticleIdList": ["10.1002/med.21431", "28052344"]}], "ReferenceList": []}], "History": [{"Year": "2019", "Month": "5", "Day": "26"}, {"Year": "2020", "Month": "1", "Day": "13"}, {"Year": "2020", "Month": "2", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["32005283", "PMC6995056", "10.1186/s13063-020-4068-y", "10.1186/s13063-020-4068-y"]}}], "PubmedBookArticle": []}